Myogenic tone is impaired at low arterial pressure in mice deficient in the low-voltage-activated Ca<sub>v</sub>3.1 T-type Ca<sup>2+</sup> channel by Björling, K. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Myogenic tone is impaired at low arterial pressure in mice deficient in the low-voltage-
activated Cav3.1 T-type Ca2+ channel
Björling, K.; Morita, H.; Olsen, M. F.; Prodan, A.; Hansen, P. B.; Lory, P.; von Holstein-
Rathlou, Niels-Henrik; Jensen, Lars Jørn
Published in:
Acta Physiologica (Print)
DOI:
10.1111/apha.12066
Publication date:
2013
Document version
Publisher's PDF, also known as Version of record
Citation for published version (APA):
Björling, K., Morita, H., Olsen, M. F., Prodan, A., Hansen, P. B., Lory, P., ... Jensen, L. J. (2013). Myogenic tone
is impaired at low arterial pressure in mice deficient in the low-voltage-activated Ca
v
3.1 T-type Ca2+ channel.
Acta Physiologica (Print), 207(4), 709-720. https://doi.org/10.1111/apha.12066
Download date: 02. Feb. 2020
Myogenic tone is impaired at low arterial pressure in
mice deficient in the low-voltage-activated CaV3.1 T-type
Ca2+ channel
K. Bj€orling,1 H. Morita,2 M. F. Olsen,1 A. Prodan,1* P. B. Hansen,3† P. Lory,4 N.-H. Holstein-
Rathlou5 and L. J. Jensen1
1 Department of Veterinary Clinical and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen,
Denmark
2 Special Patient Oral Care Unit, Kyushu University Hospital, Fukuoka, Japan
3 Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense,
Denmark
4 CNRS, Institut de Genomique Fonctionnelle, Universite de Montpellier, France
5 Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
Received 31 October 2012,
revision requested 27 December
2012,
accepted 17 January 2013
Correspondence: Department of
Veterinary Clinical and Animal
Sciences, Grønnegaardsvej 7,
Frederiksberg, Copenhagen DK-
1870, Denmark
E-mail: Lajj@sund.ku.dk
*Present address: A. Prodan,
Department of Oral Biochemistry,
Academic Centre for Dentistry
Amsterdam (ACTA), Amsterdam,
the Netherlands.
†P.B. Hansen was supported by
grants from the Danish Medical
Research Council (11-107552)
Abstract
Aim: Using mice deficient in the CaV3.1 T-type Ca
2+ channel, the aim of
the present study was to elucidate the molecular identity of non-L-type
channels involved in vascular tone regulation in mesenteric arteries and
arterioles.
Methods: We used immunofluorescence microscopy to localize CaV3.1
channels, patch clamp electrophysiology to test the effects of a putative
T-type channel blocker NNC 55-0396 on whole-cell Ca2+ currents, pres-
sure myography and Ca2+ imaging to test diameter and Ca2+ responses of
the applied vasoconstrictors, and Q-PCR to check mRNA expression levels
of several Ca2+ handling proteins in wild-type and CaV3.1
/ mice.
Results: Our data indicated that CaV3.1 channels are important for the
maintenance of myogenic tone at low pressures (40–80 mm Hg), whereas
they are not involved in high-voltage-activated Ca2+ currents, Ca2+ entry
or vasoconstriction to high KCl in mesenteric arteries and arterioles. Fur-
thermore, we show that NNC 55–0396 is not a specific T-type channel
inhibitor, as it potently blocks L-type and non-L-type high-voltage-
activated Ca2+ currents in mouse mesenteric vascular smooth muscle cell.
Conclusion: Our data using mice deficient in the CaV3.1 T-type channel
represent new evidence for the involvement of non-L-type channels in arte-
riolar tone regulation. We showed that CaV3.1 channels are important for
the myogenic tone at low arterial pressure, which is potentially relevant
under resting conditions in vivo. Moreover, CaV3.1 channels are not
involved in Ca2+ entry and vasoconstriction to large depolarization with,
for example, high KCl. Finally, we caution against using NNC 55–0396 as
a specific T-type channel blocker in native cells expressing high-voltage-
activated Ca2+ channels.
Keywords arteriolar tone, CaV3.1 T-type channel, mesenteric artery,
myogenic response, voltage-gated calcium channel.
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Voltage-gated Ca2+ channels are encoded by 10
different genes and are divided into the high-voltage-
activated Ca2+ channels, to which the L-type, P/Q-type,
N-type and R-type belong, and the low-voltage-acti-
vated Ca2+ channels to which the T-type channels
belong (Catterall et al. 2003). In vascular smooth mus-
cle cells (VSMCs), the L-type channels are important
for excitation–contraction coupling and therefore have
a dominant role in arteriolar tone regulation, blood
pressure regulation and hypertension (Nelson et al.
1990, Pratt et al. 2002, Moosmang et al. 2003). How-
ever, the contribution of non-L-type channels to vascu-
lar tone regulation is of potential clinical relevance
because a proportion of vasospasms in the coronary
and cerebral circulations are resistant to treatment with
L-type Ca2+ antagonists (Beltrame et al. 2004, Oshima
et al. 2005, Fukumoto et al. 2008, Velat et al. 2011).
Furthermore, coronary blood flow, endothelial function
and renal function in hypertensive subjects show signifi-
cant improvement after treatment with combined
L- and T-type channel blockers (Beltrame et al. 2004,
Oshima et al. 2005, Koh et al. 2007, Sasaki et al.
2009). Recently, the expression of CaV3.1 and CaV3.2
T-type Ca2+ channels was demonstrated in small arter-
ies and arterioles from the rat mesenteric (Gustafsson
et al. 2001, Jensen et al. 2004, Braunstein et al. 2009),
cremasteric (VanBavel et al. 2002), renal (Hansen et al.
2001) and cerebral (Kuo et al. 2010) circulations.
Because the expression of L-type channels and the effect
of L-type channel blockers were shown to be reduced in
the most peripheral branches of the mesenteric circula-
tion (Morita et al. 1999, 2002, Gustafsson et al. 2001,
Jensen et al. 2004), it was suggested that the T-type
channels are especially important for tone regulation in
the most peripheral resistance vessels of the systemic
circulation (Gustafsson et al. 2001, Jensen et al. 2004,
Ball et al. 2009). Recombinant T-type channels are
low-voltage-activated and undergo rapid voltage-
dependent inactivation at depolarized potentials more
positive than 50 mV (Perez-Reyes 2003). Neverthe-
less, previous studies in rat mesenteric resistance vessels
have shown that high-voltage-activated whole-cell Ca2+
currents and Ca2+ entry to high KCl in VSMCs, which
were resistant to L-type channel blockade using nifedi-
pine, were highly sensitive to several T-type channel
blockers, such as mibefradil, NiCl2, pimozide, ethosuxi-
mide, NNC 55–0396 and R(-)-efonidipine (Morita
et al. 2002, Jensen et al. 2004, Braunstein et al. 2009).
In rat mesenteric arterioles, P/Q-type channels were not
expressed and the Ca2+ entry to high KCl was not
blocked by highly specific peptide toxin inhibitors of P/
Q-type, N-type or R-type channels (Jensen et al. 2004).
It was therefore speculated that a splice variant of
T-type channels is expressed in mesenteric resistance
vessels which activate and mediate Ca2+ entry via
non-inactivating window currents at membrane poten-
tials more depolarized than the hyperpolarized poten-
tials at which recombinant pore-forming subunits of
the CaV3.1 channels are activated (Jensen & Holstein-
Rathlou 2009).
Myogenic tone is associated with a near-linear relation-
ship between intraluminal pressure and depolarization of
VSMCs in intact cerebral and skeletal muscle arteries,
going from a membrane potential of approx. 60 mV at
low pressure (20–40 mm Hg) to approx. 30 mV at
high pressure (100–120 mm Hg) (Knot & Nelson 1998,
Kotecha & Hill 2005). L-type channel splice variants in
smooth muscle cells show non-inactivating window cur-
rents in the voltage range from 55 to 10 mV (Liao
et al. 2007), and Ca2+ entry through L-type channels is
known to be important for maintaining myogenic tone in
resistance vessels (Davis & Hill 1999). Recombinant
CaV3.1 T-type Ca
2+ channels are activated and inacti-
vated at relatively more hyperpolarized membrane
potentials than are L-type channels, and their activation
and inactivation curves overlap at more hyperpolarized
membrane potentials in the range between 65 and
55 mV, thus giving rise to a small, non-inactivating
window current in this voltage range (Monteil et al.
2000). We therefore speculated that a non-inactivating
Ca2+ influx is activated at low pressures in mouse mesen-
teric VSMCs due to window currents through CaV3.1
T-type channels. However, conclusive studies have
been hampered by the lack of specific T-type channel
blockers, although some recent studies suggested that
the compounds NNC 55–0396 and R(-)-efonidipine are
T-type specific (Furukawa et al. 2004, Huang et al.
2004). Recently, transgenic mice born with a deletion of
either the CaV3.1 (Kim et al. 2001) or the CaV3.2 (Chen
et al. 2003) T-type Ca2+ channels have become available.
Using mice deficient in the CaV3.1 T-type channel, the
aim of the present study was therefore to elucidate the
molecular identity of non-L-type channels involved in
vascular tone regulation in mesenteric arteries and arteri-
oles by comparing the vasoconstrictor effects of (i) an
increase in intraluminal pressure, (ii) application of a
depolarizing KCl-containing solution and (iii) exposure of
the vessels to physiological concentration of noradrena-
line. This study is relevant for clarifying the contribution
of T-type channels to vascular tone regulation in mesen-
teric arteries and arterioles, which had previously been
prevented by the lack of specific T-type antagonists.
Materials and methods
Animals and tissue preparations
Studies were conducted using CaV3.1
/ mice and
weight- and age-matched C57BL/6J mice (Taconic
Farm Inc., Lille Skensved, Denmark). Mice knockout
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for the CaV3.1 T-type Ca
2+ channel (CaV3.1
/), origi-
nally developed in HS Shin’s laboratory (Kim et al.
2001), were backcrossed for more than 10 generations
to the C57BL/6J genetic background. Genotyping was
performed as described previously (Kim et al. 2001).
The mice of both genotypes were 5–8-month-old males
and weighed 2639 g. There were no clinical signs or
dysfunction due to CaV3.1 deletion or age. Mice were
killed immediately before use by cervical dislocation.
The intestines were quickly removed and submersed in
oxygenated (95% O2/5% CO2) Krebs buffer at room
temperature. Second- or third-order mesenteric arteries
(<200 lm lumen) were quickly removed using sharp-
ened forceps and ophthalmic scissors under a stereo
microscope (Leica M80; Leica Microsystems, Wetzlar,
Germany) with cold light illumination (Leica
CLS150XE; Leica Microsystems, Wetzlar, Germany),
and used for pressure myography, Q-PCR and
immuno-fluorescence microscopy. Mesenteric terminal
arterioles (<40 lm lumen) were excised from the fat
pads adjacent to the border of the ileum as previously
described (Braunstein et al. 2009) and used for Ca2+
imaging experiments. For whole-cell patch clamp elec-
trophysiology, 10–11-week-old Sprague Dawley rats
(N = 10) and 9–12-week-old C57BL/6J mice (N = 4)
of either sex were used. These rats and mice were anaes-
thetized by exposure to sevoflurane and killed by
cervical dislocation, and small mesenteric arteries
(<200 lm) were excised and used for isolation of single
VSMCs. This study conforms to good publication
practice in physiology (Persson & Henriksson 2011).
Pressure myography
Mouse mesenteric arteries were mounted in a pressure
myograph system (120 CP, DMT A/S, Aarhus,
Denmark) between two fire-polished glass pipettes with
matching tip diameter (approx. 80 lm) for intraluminal
perfusion and diameter measurement. The pressure my-
ograph was placed on the stage of an inverted micro-
scope (Olympus IX71; Olympus Danmark A/S,
Ballerup, Denmark), and vessels were viewed through a
4X objective. The myograph chamber (5 mL) was con-
tinuously superfused (2 mL min1) with oxygenated
(95% O2/5% CO2) Krebs buffer, while arteries were
being slowly pressurized and heated to 37 °C. To avoid
bending of the artery at the maximal pressure of
120 mm Hg, the arteries were gently stretched to their
approximate in situ length while maintaining the longi-
tudinal force measurement between 0.1 and 0.35 mN.
The luminal perfusion was blocked in the downstream
direction to perform the measurements under no-flow
conditions. It was checked that the pressure did not
drop more than 1–2 mm Hg on the outflow side of the
vessel to avoid vessels with side branches or leaks.
Subsequently, the pressure was gently lowered to
40 mm Hg, and after resting for 5–10 min, the artery
was constricted with Krebs buffer containing 75 mM
KCl (K75) for 3–5 min. After washout of K75 and rest-
ing for 5–10 min, the artery was again constricted for
3–5 min by adding 1 lM noradrenaline (NA) to the
superfusate. Only arteries without leaks and showing a
uniform constriction to K75 and NA were included in
the study. Arteries included in the study were equili-
brated with Krebs buffer at 80 mm Hg for 30–40 min
before commencing the myogenic pressure step proto-
col. The control pressure curve was performed by
changing the pressure between 20 and 120 mm Hg in
20 mm Hg increments while letting the artery constrict
for 5 min at each pressure. After the control pressure
curve was constructed, the artery was rested for 30 min
before repeating the pressure protocol in the presence
of 1 lM nifedipine. Finally, after the second pressure
curve, the myograph chamber was superfused with Ca2
+-free Krebs’ buffer + 2 mM EGTA for at least 10 min
before repeating the pressure step protocol to obtain
the passive pressure curve. During experiments, the
outer diameter of the artery was measured using Myo-
view software (DMT A/S), and diameter, longitudinal
force, temperature and pressure data were stored to a
PC hard disk at 1 Hz. Offline analysis was used to cal-
culate the mean steady-state diameters during the last
30 s at each pressure step. Mean diameters for K75 and
NA measurements were measured at their steady-state
diameter. There were no time-dependent diameter
changes with K75 or NA after the steady-state diameter
was reached.
Calcium imaging
The intracellular [Ca2+] measurements using Fura-PE3
ratiometric imaging of unpressurized mouse mesen-
teric terminal arterioles were performed at room tem-
perature, as previously described (Jensen et al. 2004).
The Ca2+ responses were evaluated as the peak Fura-
PE3 Ratio to HB-PSS containing 60 mM KCl (K60).
For each arteriole, normal HB-PSS was added first a
couple of times to check for motion artifacts. Then,
arterioles were challenged with K60 three times inter-
mitted by washing steps for 5 min. Then arterioles
were incubated with the Ca2+ antagonists for 10 min,
followed by another series of challenges with K60. In
most experiments, drugs were then washed away, and
a third series of K60 challenge was performed.
Whole-cell patch clamp electrophysiology
Isolation of single VSMCs from mouse and rat mesen-
teric arteries (<200 lm) and the whole-cell patch
clamp procedure was performed, as previously
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published (Morita et al. 1999). In brief, short seg-
ments of the distal part of the isolated arteries were
transferred to PSS with 1 mM Ca2+ and 0.5 mM
papain (Worthington) and 0.5 mM 1,4-dithioerythritol
(Sigma; Sigma-Aldrich Denmark ApS, Brøndby,
Denmark), and incubated at 37 °C for 15 min, fol-
lowed by transfer to 1 mM Ca2+-containing PSS with
2 mM collagenase (type I; Worthington Biochemical
Corp., Lakewood, NJ, USA) and incubated at 37 °C
for 45 min. Single cells were dissociated by triturating
the digested segments with a large-bore Pasteur pipette
in Ca2+-free PSS and stored at 4 °C until use. A
low-noise, high-performance patch clamp amplifier
(Axopatch 1D; Axon Instruments, Foster City, CA,
USA) driven by a PC in conjunction with an A/D, D/A
board (TL-1, Axon Instruments) was used to generate
and apply voltage pulses to clamped cells and to
record the corresponding membrane currents. Current
signals were low-pass filtered at 1 kHz and digitized
at 2 kHz before being stored to the PC hard disk. Lin-
ear leak subtraction was made using the hyperpolariz-
ing P/4 or P/2 routine. Under the present experimental
conditions, the series resistance of cells stayed almost
constant throughout the experiment, and 50–70% of
the series resistance was compensated. NNC 55-0396
was dissolved in water and added in increasing concen-
trations (10–10 lM) when steady-state inhibition was
reached after approx. 100-s exposure. In initial experi-
ments (N = 3) using only 1 lM NNC 55-0396 to block
the total IBa, the remaining blocker-resistant current
was totally abolished by the addition of Cd2+ (200 lM).
Immunofluorescence microscopy
Isolated second- and third-order mouse mesenteric
arteries (3–5 from each mouse) were fixed in 2%
paraformaldehyde dissolved in PBS for 1 h and subse-
quently cryo-protected in 30% sucrose for 2 h, or
until they were submerged at the bottom of the
sucrose solution. Cryo-protected arteries were embed-
ded in Tissue-Tek; Sakura Finetek Denmark ApS,
Copenhagen, Denmark contained in a plastic mould
and immediately quick-frozen in liquid nitrogen.
Freeze sections (5 lm) were cut on a cryostat (Leica
CM 1950) and collected on precleaned Superfrost Plus
microscope slides (Thermo Scientific; Fisher Scientific
GmbH, Schwerte, Germany). The immunostaining
procedure was performed, as previously described
(Jensen et al. 1999). In brief, frozen sections were left
at room temperature for 1 h before they were
hydrated 3 9 5 min in PBS. Unspecific staining was
blocked with 5% donkey serum in PBS for 50 min at
RT. The primary CaV3.1 polyclonal antibody (gift
from Dr. LL Cribbs, Loyola University, Ill.) was
diluted 1 : 1500 in PBS and added to the sections for
90 min at RT or overnight at 4 °C. The specificity of
the CaV3.1 antibody has previously been established
(Rodman et al. 2005). The antigenic peptide sequence
(FVCQGEDTRNITNKSDCAEAS) used for preabsorp-
tion experiments to verify the specificity of the anti-
body towards the CaV3.1 epitope was synthesized by
United Peptide Corp. (Bethesda, MD, USA). In paral-
lel preabsorption experiments, the primary antibody
diluted in PBS was incubated with the antigenic pep-
tide at 40–50 lg/mL for 1 h at RT while shaking. The
antibody–antigen mixture was vortexed and spun
down shortly before applying it to the tissue sections
and incubated as for primary antibody. In each exper-
iment, a negative control with secondary antibody
alone was also included. After incubation with pri-
mary antibody, the washing step consisted of wash
with high-salt PBS for 5 min (to reduce non-
specific staining) followed by normal PBS for
2 9 5 min. Secondary antibody (1 : 800; Alexa
Fluor 488 Donkey anti-rabbit IgG, Molecular
Probes; Life Technologies Europe BV, Nærum,
Denmark) and Rhodamin-Phalloidin (1 : 400, Molec-
ular Probes) were diluted in PBS and added for
60 min at RT. The washing step was repeated. Sec-
tions were treated with DAPI (0.1 lg/mL) in PBS for
30 min at RT. Finally, sections were covered with
Immersion Liquid Type F (Leica), and cover slip was
mounted for inspection. Sections were imaged with a
Leica DM RB epifluorescence microscope through a
Leica PL Fluotar oil-immersion objective (40X/1.00-
0.50) using an external light source (EL 6000), digital
camera (DFC 350 FX) and software (LAS Vers. 2.8.1)
from Leica. For each experiment, all sections were
imaged under identical microscope and camera set-
tings. There was no visible staining in the negative
controls using secondary antibody alone. Using Adobe
Photoshop CS4, captured images were cropped,
rotated, and the brightness and contrast were enhanced
equally in sections incubated with primary antibody
and primary antibody + peptide preincubation.
Quantitative real-time PCR (Q-PCR)
After dissection, second- and third-order branches of
mouse mesenteric artery (3–4 from each mouse) were
stored in RNAlater (Sigma) at 4 °C until used. Extrac-
tion of total RNA was performed using a TissueLyzer
homogenizer and RNEasy Micro kit (Qiagen; Qiagen
GmbH, Hilden, Germany) according to the manufac-
turer’s instruction. cDNA was produced from freshly
extracted total RNA using a Promega kit according to
the manufacturer’s instruction. Both RT+ and RT–
samples were prepared for each mouse. cDNA from
mouse whole brain was prepared in the same way and
used as a calibrator sample. Primers were picked using
Acta Physiologica © 2013 Scandinavian Physiological Society, doi: 10.1111/apha.12066712
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Primer Blast or Primer 3 (see Table 1). A Blast search
confirmed that the primers did not contain perfect
matches to unintended targets. Conventional PCR using
mouse cDNA and intron-spanning primers did not
reveal any genomic DNA contamination. Q-PCR was
performed using a LightCycler 480 apparatus (Roche;
Roche Diagnostics A/S, Hvidovre, Denmark) and
SYBR Green PCR Master Mix. The standard Q-PCR
cycle protocol was annealing at 60 °C for 10 s, and
elongation at 72 °C for 20 s. Production of a standard
curve for each primer pair using calibrator cDNA
showed efficiencies in the range [1.83–2.10] and slopes
in the range [3.13 to 3.67]. The melting curve analy-
ses revealed single peaks, only. For each primer pair,
the amplified product was of the expected size, and
the RT– and H2O-loaded negative controls did not
reveal any amplification. The reference gene b-actin
(rActB) expression did not vary significantly between
samples.
Solutions and chemicals
Krebs Buffer contained the following concentrations of
salts (mM): NaCl 118; KCl 4.7; MgSO4 1.2; CaCl2 2;
NaHCO3 25; KH2PO4 1.2. In the Krebs buffer with
75 mM KCl (K75), NaCl was substituted with equimo-
lar amounts of KCl. In the Ca2+-free Krebs buffer,
CaCl2 was replaced with 2 mM EGTA. Hepes-buffered
physiological saline solution (HB-PSS) contained the
following concentrations of salts (mM): NaCl 140; KCl
5; MgCl2 1.2; CaCl2 2; Hepes 10. In the HB-PSS with
60 mM KCl (K60), NaCl was substituted with equimo-
lar amounts of KCl. A HB-PSS without CaCl2 (no
EGTA) was used during the mounting procedure of
small arteries in pressure myograph experiments. Phos-
phate-buffered saline solution (PBS) contained (mM):
NaCl 137; KCl 2.7 Na2HPO4 10; KH2PO4 1.76. In
high-salt PBS (HS-PBS), the concentration of NaCl was
increased to 411 mM. Glucose (5 mM) was added to
each buffer (except PBS) immediately before use. pH
was adjusted to 7.4 by equilibration with 5% CO2
for Krebs buffer(s), and by adding 1 N NaOH for
HB-PSS, PBS and HS-PBS. For whole-cell patch clamp
experiments, a HB-PSS was used as bath solution,
except that 5 mM BaCl2 replaced Ca
2+ as charge
carrier and that pH was adjusted to 7.4 with Tris base.
The pipette (internal) Cs+ solution contained (in mM)
Cs+ 140, Mg2+ 2.0, Cl 144, Phospho-creatine 5,
Na2ATP 1, EGTA 10 and HEPES 10 (adjusted to pH
7.2 with Tris base). Nifedipine, NNC 55-0396, NiCl2,
BaCl2, CdCl2, Pluronic F-127, Cremophore EL, DAPI
and all other salts and chemicals were from Sigma
Aldrich Co.
Statistics
Data were presented as raw data or mean  SEM
with statistical significance tested using Student’s
t-test, except for Fig. 2a,b where the Control and
Nifedipine pressure curves were evaluated versus the
passive curves using a two-way repeated measures
ANOVA with Bonferroni post-test for comparing indi-
vidual pressure levels (multiple comparisons). A
P-value of <0.05 was considered statistically signifi-
cant. In Fig. 3b, the pharmacological effects were cal-
culated as the increase from baseline Fura-PE3 R to
K60 exposure (DR) before and after addition of Ca2+
channel blockers and expressed as the % remaining
Ca2+ entry in mesenteric arterioles during drug expo-
sure according to: (DRdrug/DRcontrol)*100. The vaso-
constriction to K75 and NA in mouse mesenteric
artery was expressed as the difference in % vascular
tone (PD – AD/PD)*100 between the resting diameter
in normal Krebs buffer and Krebs buffer with high
KCl or NA. Concentration-inhibition curves for NNC
55-0396 on IBa and NI-IBa were analysed by fitting
data points averaged from 4 cells by the Hill equation
for estimation of the 50% inhibitory concentration
(IC50) and Hill coefficient (nH), respectively. Q-PCR
data were evaluated either as Ratios of target gene to
ActB cycle thresholds (Ct-values) in small mesenteric
artery samples, or using the 2DDCt method of normalized
Table 1 QPCR primers
Gene name Forward primer (5′-3′) Reverse primer (5′-3′) Product size (BP) Accession no.
Cacna1c CGTTCTCATCCTGCTCAACA GGTGTACCTCGGTGATTGCT 236 BC138031
Cacna1 h CCTTTCTCAGCGTCTCCAAC GCCACAATGATGTCAACCAG 169 BC138026
Cacna1a TGCTGTGCTCACTGTTTTCC TTCTCCACACGTTCCCTTTC 198 NM007578
Trpc1 GACATTCCAGGTTTCGTCTTG GTCAGCACTAAGTTCAAACGC 107 NM011643
Trpc3 GATCGAGGATGACAGTGATGTAG TCCATCATCGAAGTAGGAGAGC 73 NM019510
Trpc6 TACAATCTGGCCAGGATAAAGTG CACAGCGATTGCATAAAGACC 75 NM013838
Adra1a ATTGTGGTGGGATGCTTCGT ACTGTTTCCGGTGGCTTGAA 95 NM013461
Adra1b GCCAAAACCTTGGGCATTGT AAGTAGCCCAGCCAGAACAC 140 NM007416
Adra1d CAAGACCCTAGCCATCGTCG GAAGACGCCCTCTGATGGTT 112 NM013460
Actb AGCCATGTACGTAGCCATCC CTCTCAGCTGTGGTGGTGAA 228 NM007393
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relative ratios (Livak & Schmittgen 2001). The latter
was calculated by the formula: Normalized relative
ratio = 2DDCt , where DCt = Ct (target) – Ct (rActB),
and DDCt = DCt (sample) – DCt (calibrator). The two
calculation methods yielded similar results and statisti-
cal significance.
Results
We initially investigated by indirect immunofluores-
cence microscopy the expression and localization of
CaV3.1 T-type Ca
2+ channels in mouse mesenteric
artery. As shown in a cross-section of an artery in
Fig. 1 (Panel A), the green CaV3.1 staining is abun-
dant in the arterial wall. CaV3.1 expression was not
detectable in ECs, because the nuclei of ECs (white
arrows) facing the lumen of the vessel are not covered
by green CaV3.1 staining. In the longitudinal section
through the tunica media (Panel C), it is clearly shown
that CaV3.1 staining is abundant in VSMCs. We con-
firmed the specificity of the primary antibody for the
CaV3.1 epitope by showing that the green staining is
absent in sections of the same arteries labelled with
primary antibody preincubated with its antigenic pep-
tide (Panels B and D). Taken together, this expression
pattern of CaV3.1 is consistent with our previous find-
ings in rat mesenteric arterioles and small arteries
(Braunstein et al. 2009).
We hypothesized that a CaV3.1 T-type channel win-
dow current could be involved in maintenance of
myogenic tone at low pressures associated with rela-
tively small myogenic depolarization in mouse mesen-
teric arteries. This was investigated by pressure
myograph experiments in which the steady-state con-
striction to intraluminal pressures in the range from
20 to 120 mm Hg was recorded. As shown in Fig. 2a,
arteries from age-matched wild-type mice were signifi-
cantly constricted in the pressure range from 40 to
120 mm Hg in the control situation with Krebs buffer
compared with the passive situation where the vessels
were exposed to Ca2+-free solution. In the wild-type
mice, a concentration of nifedipine (1 lM) sufficient to
abolish all L-type channels expressed in smooth mus-
cle (Morel et al. 1998), resulted in a pressure curve
that was not significantly different from the passive
curve, except at low pressure (40 mm Hg). This indi-
cated that a non-L-type Ca2+ channel might be impor-
tant at low pressure. Interestingly, in arteries from
CaV3.1
/ mice, the myogenic tone was abolished at
low pressures from 40 to 80 mm Hg, whereas the
(a) (b)
(c) (d)
Figure 1 Immunolocalization of CaV3.1 protein (green staining) in mouse small mesenteric artery. Red colour represents
smooth muscle a-actin staining and blue colour represents nuclei. (a) cross-section of an artery showing labelling of CaV3.1 in
the vascular wall. Note the absence of green staining around EC nuclei (white arrows). (b) Cross-section of the same artery
stained with primary CaV3.1 antibody preincubated with its antigenic peptide. Note the absence of green CaV3.1 staining in this
arterial section. (c) Longitudinal section through the tunica media in mouse mesenteric artery. Individual vascular smooth mus-
cle cells (VSMC)s labelled with green CaV3.1 staining are clearly distinguished. (d) Longitudinal section through the tunica
media of mesenteric artery incubated under similar conditions with primary antibody + antigenic peptide. Note the suppression
of green staining in VSMCs in this artery. Images in (a) vs. (b) and (c) vs. (d) were captured under identical camera and micro-
scope settings. Images are representative of staining in at least 3 different wild-type mice.
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arterial diameter and myogenic tone at 100 and
120 mm Hg were similar to the age-matched wild-
type mice (Fig. 2b). These data strongly suggest that
in wild-type mouse mesenteric artery, CaV3.1 T-type
channels are involved in the maintenance of myo-
genic tone at low pressures up to 80 mm Hg, that
CaV3.1 channels are inactivated at high pressures of
100–120 mm Hg, and that the L-type channels are
strongly activated in this pressure range.
In previous studies, it has been suggested that a
splice variant of T-type channels is expressed in
mesenteric resistance vessels and contribute to sus-
tained Ca2+ entry at membrane potentials normally
found in VSMCs (Jensen & Holstein-Rathlou 2009).
To investigate this possibility, we compared the Ca2+
entry and vasoconstriction to high KCl in age-matched
wild-type and CaV3.1
/ mice. As shown in Fig. 3a,
the Ca2+ increase to high KCl in mouse mesenteric
terminal arterioles (<40 lm) was similar in wild-type
and CaV3.1-deficient mice. Furthermore, the vasocon-
striction measured as the increase in vascular tone
from baseline to high KCl (DTone) in small mesenteric
arteries (<200 lm) was also similar in wild-type and
CaV3.1-deficient mice (Fig. 3c). These data clearly
show that CaV3.1 channels are not involved in the
nifedipine-insensitive responses to high-voltage activa-
tion with KCl. How does this comply with the
pronounced effects of NNC 55-0396, which was
recently shown to potently inhibit recombinantly
expressed CaV3.1 channels with no effect on high-
voltage-activated Ca2+ currents (Huang et al. 2004).
To investigate this, we next tested the pharmacology
of KCl-induced Ca2+ entry in mesenteric arterioles
from CaV3.1
/ mice (Fig. 3b). About 40% of the
Ca2+ entry was insensitive to nifedipine, and when
adding the CaV3.2-specific blocker NiCl2 (30 lM) on
top of nifedipine, there was no further inhibition of
the Ca2+ entry. These data show that neither CaV3.1
nor CaV3.2 T-type Ca
2+ channels mediate nifedipine-
insensitive Ca2+ entry to KCl. Furthermore, NNC
55-0396 (10 lM), irrespective of whether it was added
on top of nifedipine or NiCl2, abolished all Ca
2+ entry
to high KCl in mesenteric arterioles from CaV3.1-
deficient mice. These data clearly demonstrate that
NNC 55-0396 is not a specific T-type channel
blocker.
The question still remained whether NNC 55-0396
can be used to distinguish between high-voltage-
activated Ca2+ channels of the L-type vs. non-L-type
in native mesenteric artery VSMCs. To investigate this
further, we tested the effects of NNC 55-0396 on
high-voltage-activated whole-cell barium (Ba2+) cur-
rents (IBa) before or after addition of 10 lM nifedipine
to block all L-type channel activity. Fig. 4a,b show
original recording and mean Ba2+ currents found in
mouse mesenteric VSMCs. It is seen that the total
IBa is activated by stepping from a holding potential
of 80 mV to depolarized potentials in the range
from 30 mV to +60 mV with a peak of the I/V-
curve at 0 to +10 mV. The current remaining after
addition of nifedipine (NI-IBa) amounted to approx.
20% of the total IBa. As the Ba
2+ currents in mouse
VSMCs were rather small, we continued investigating
the effects of NNC 55-0396 in rat mesenteric artery
VSMCs. In Fig. 5a–c is shown that NNC 55-0396
dose dependently blocks both total IBa and NI-IBa in
rat mesenteric artery VSMC with IC50 values of
0.59 lM and 0.96 lM, respectively. These data clearly
show that NNC 55–0396 blocks high-voltage-acti-
vated Ca2+ channels of both L-type and non-L-type
with similar high potency and should therefore not be
used in native VSMCs to distinguish between different
high-voltage-activated Ca2+ channels.
(a)
(b)
Figure 2 Myogenic response in small mesenteric artery of
wild-type and CaV3.1
/ mice. (a) Control pressure curve
shows diameter of artery when superfused with normal Krebs
buffer. Nifedipine was used in the Krebs buffer to block all
L-type channels. The passive pressure curve was obtained by
superfusing arteries with a Ca2+-free (+EGTA) Krebs buffer.
Note the development of myogenic tone at pressures from 40
to 120 mm Hg seen as a significant constriction compared
with the passive curve. Note that nifedipine did not signifi-
cantly block the myogenic tone at 40 mm Hg. (b) Myogenic
tone under control condition is not significant at pressures
from 20 to 80 mm Hg. Nifedipine abolishes myogenic tone
at 100 to 120 mm Hg. (**P < 0.01 control vs. passive diam-
eter; ***P < 0.001 control vs. passive diameter; #P < 0.05 in
nifedipine-treated vs. passive diameter). The number of ves-
sels/animals is shown in brackets.
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We also tested the vasoconstrictor effects of a sub-
maximal concentration of noradrenaline (NA 1 lM) in
mouse small mesenteric arteries pressurized at
40 mm Hg. Surprisingly, NA elicited a significantly
stronger vasoconstriction (increase in vascular tone
from baseline) in mice deficient in the CaV3.1 channel
than in age-matched wild-type mice (Fig. 3d). We
speculated that this could be due to an upregulation
in the expression of different Ca2+ handling proteins
and therefore tested by Q-PCR the mRNA expression
of several isoforms of voltage-gated Ca2+ channel,
transient receptor potential channel subfamily C, and
a1-adrenergic receptor in mouse small mesenteric
arteries. As shown in Table 2, these Ca2+ handling
proteins were not differentially expressed in mesen-
teric arteries from age-matched wild-type mice and
CaV3.1-deficient mice.
Discussion
The involvement of T-type channels in the regulation
of arteriolar tone has long been controversial for sev-
eral reasons. Firstly, the membrane potentials at which
the T-type channels are activated and inactivated are
more hyperpolarized than what has been measured in
VSMCs of pressurized arteries and arterioles (Perez-
Reyes 2003, Jensen & Holstein-Rathlou 2009). Sec-
ondly, despite the fact that many studies have shown
the existence of a non-L-type Ca2+ channel, which con-
tributes to arteriolar tone in mesenteric, cremasteric,
renal and cerebral vessels (Gustafsson et al. 2001,
Hansen et al. 2001, Morita et al. 2002, VanBavel
et al. 2002, Jensen et al. 2004, Kuo et al. 2010), these
studies have relied on mibefradil and other non-specific
T-type channel blockers with a known effect on high-
voltage-activated Ca2+ channels (Bezprozvanny &
Tsien 1995, Aczel et al. 1998, Jimenez et al. 2000,
Moosmang et al. 2006). In an attempt to clarify the
contribution of T-type channels to arteriolar tone regu-
lation, we employed mice deficient in the CaV3.1
subtype of T-type channels and tested the three follow-
ing hypotheses: (i) Do CaV3.1 T-type channels contrib-
ute to myogenic tone at low arterial pressure, under
which the membrane potential of VSMCs in pressur-
ized arteries was previously measured to be in the
range from 60 to 50 mV (Knot & Nelson 1998,
(a) (b)
(c) (d)
Figure 3 (a) Measurements of intracellular Ca2+ increase (Fura-PE3 Ratio) to high KCl (60 mM) in mesenteric terminal arteri-
oles (<40 lm) from wild-type and CaV3.1-deficient mice. (b) Remaining Ca
2+ increase (% of control response) to K60 in termi-
nal arterioles from CaV3.1
/ mice during exposure to L-type channel inhibitor nifedipine (10 lM), CaV3.2 T-type Ca
2+ channel
inhibitor NiCl2 (30 lM) and putative T-type channel blocker NNC 55-0396 (10 lM). N.D. = not detectable. (c, d) Vasoconstric-
tion (D Tone) to high KCl (75 mM) and noradrenaline (1 lM) in mesenteric small arteries (<200 lm) pressurized to 40 mm Hg.
The number of vessels/animals is shown in brackets.
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Kotecha & Hill 2005). (ii) Do CaV3.1 T-type channels
partially mediate Ca2+ influx and vasoconstriction to
high-voltage activation using high KCl concentration
in mouse mesenteric arteries (<200 lm) and arterioles
(<40 lm)? (iii) Is NNC 55–0396 a specific T-type
channel blocker?
With respect to the first hypothesis, it was clearly
shown that the myogenic tone in CaV3.1
/ mice was
abolished in the pressure range from 40 to 80 mm Hg,
as compared with age-matched wild-type mice (Fig. 2).
We did not measure the membrane potential of pres-
surized mouse mesenteric arteries to confirm that it
was in the range required for sustained activation of
CaV3.1 channels through window currents. However,
our data indicate that L-type channels were not cru-
cial for myogenic tone at low arterial pressure, because
nifedipine (1 lM) was ineffective at blocking myogenic
tone at 40 mm Hg in the wild-type mice. Furthermore,
the fact that the myogenic response at 100–120 mm Hg
was very powerful in CaV3.1
/ mice and constricted
the arteries to attain the same diameter as in the
wild-type mice, suggests that the mechanosensor
involved in the development of spontaneous myogenic
tone is intact in mice deficient in the CaV3.1 channels.
In addition, nifedipine (1 lM) was effective in blocking
myogenic tone at 100–120 mm Hg in wild-type and
CaV3.1
/ mice, which lends further support to the
notion that L-type channels are crucial for mainte-
nance of myogenic tone at high arterial pressure. The
role of CaV3.1 channels in myogenic tone is supported
by the presence of the CaV3.1 protein in the smooth
muscle layer of mouse mesenteric arteries (Fig. 1). It is
therefore suggested that CaV3.1 channels are activated
and contribute to myogenic tone at low arterial pres-
sure and that they are inactivated at high arterial pres-
sure where L-type channel activation is responsible for
the maintenance of myogenic tone. It remains to be
established whether T-type channels are important for
basal tone in vivo, but as the pressure in mesenteric
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arteries in conscious rats was in the range from 60 to
80 mm Hg (Fenger-Gron et al. 1995), we suggest that
T-type channels may to some extent contribute to the
basal tone under resting conditions.
Our finding that the noradrenergic tone measured at
40 mm Hg in mesenteric arteries was augmented in
CaV3.1
/ mice compared with their wild-type controls
(Fig. 3d) deserves attention. None of the Ca2+ chan-
nels, TRPC channels or a1-adrenergic receptor subtypes
present in mouse mesenteric arteries were differentially
expressed at the mRNA level in the wild-type vs.
knockout animals (Table 2). Although we cannot be
sure that these channels and receptors are not upregu-
lated at the protein level in the CaV3.1
/ mice, our
data suggest that the augmented noradrenergic tone is
not explained by a simple upregulation of these mecha-
nisms. However, the increase in noradrenergic tone
could be a natural compensation for mice born with a
deletion of the CaV3.1 channels, as the myogenic tone
was abolished at the lower arterial pressures, which
would necessitate a secondary mechanism to compen-
sate for the loss in vascular tone. Furthermore, the
CaV3.1
/ animals are bradycardic, due to a slowing
of the sinoatrial node pacemaker rhythm and the A-V
conduction, but they have normal mean arterial blood
pressure (Mangoni et al. 2006). It is tempting to specu-
late that the noradrenaline sensitivity of the resistance
vessels is upregulated in CaV3.1
/ animals to increase
the peripheral resistance enough to keep the animals
normotensive under resting conditions.
With respect to the second hypothesis, our data
clearly showed that KCl-induced Ca2+ entry and vaso-
constriction in mesenteric arteries and arterioles was
not different in wild-type and CaV3.1-deficient mice
(Fig. 3a,c). Furthermore, the nifedipine-insensitive Ca2+
increase to high KCl in arterioles from CaV3.1
/ ani-
mals was not sensitive to a low concentration of Ni2+
(30 lM), which is considered to be specific for CaV3.2
channels (Fig. 3b). Taken together, our data from the
wild-type and knockout mice clearly shows that
CaV3.1 and CaV3.2 T-type Ca
2+ channels do not medi-
ate depolarization-induced Ca2+ entry and vasocon-
striction to high KCl. We must assume that this is due
to the fact that the depolarization induced by high KCl
is so large that the T-type channels are inactivated.
This conclusion is supported by a patch clamp study in
rat mesenteric artery VSMCs showing that nifedipine-
insensitive whole-cell Ca2+ currents with T-type-like
pharmacology was not reminiscent of recombinant
CaV3.1 T-type Ca
2+ channels expressed in HEK cells
(Morita et al. 2002). Previous studies argue against the
possibility of several high-voltage-activated Ca2+ chan-
nels as candidates for the nifedipine-insensitive Ca2+
entry pathway in mesenteric arteries and arterioles,
because specific peptide toxins targeting P/Q-type,
N-type, or R-type channels were not effective (Morita
et al. 2002, Jensen et al. 2004). In addition, the
mesenteric nifedipine-insensitive Ca2+ currents did not
match those of recombinant CaV2.3 R-type channels
expressed in HEK cells (Morita et al. 2002). One hypo-
thetical explanation for our observations could be that
depolarization per se triggers Ca2+ store release (Urena
et al. 2007), and indirectly activates plasma membrane
Ca2+ channels by emptying of these stores. However,
the Ca2+ currents measured with Ba2+ as charge carrier
in the presence of 10 lM nifedipine in mesenteric artery
VSMCs (Morita et al. 1999, 2002) are not similar to
any of the storage-operated Ca2+ permeable channels
of the TRPC family, so the identity of the high-voltage-
activated nifedipine-insensitive Ca2+ channel awaits
further elucidation.
With respect to the third hypothesis, NNC 55-0396
potently inhibited high-voltage-activated Ca2+ influx in
CaV3.1
/ mice and Ba2+ currents in the presence and
absence of nifedipine with similar potency. These
data are supported by a recent study in which 1 lM
NNC 55-0396 abolished the total high-voltage-activated
Ba2+ currents in rat basilar artery myocytes (Kuo et al.
Table 2 Q-PCR data
Target gene Protein symbol
WT mice: target
gene expression (N)
CaV3.1
/ mice: target
gene expression (N) P-value (t-test)
Cacna1c CaV1.2 (L-type) 0.225  0.052 (7) 0.231  0.037 (6) 0.93
Cacna1 h CaV3.2 (T-type) 0.202  0.024 (7) 0.155  0.049 (6) 0.39
Cacna1a CaV2.1 (P/Q-type) 0.024  0.003 (7) 0.034  0.010 (3) 0.26
Trpc1 TRPC1 0.177  0.011 (7) 0.181  0.022 (3) 0.87
Trpc3 TRPC3 0.078  0.017 (7) 0.051  0.025 (3) 0.41
Trpc6 TRPC6 0.137  0.017 (7) 0.149  0.022 (6) 0.66
Adra1a a1A-R 0.363  0.028 (7) 0.279  0.064 (3) 0.32
Adra1b a1B-R 0.020  0.003 (7) 0.024  0.008 (3) 0.67
Adra1d a1D-R 0.102  0.013 (7) 0.077  0.012 (3) 0.20
Normalized mRNA expression data are presented as 2DDCt -value (see Methods). N equals the number of mice studied. For each
mouse studied, RNA from three to four small mesenteric arteries was pooled and used for the Q-PCR analysis.
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2010). These findings demonstrate that NNC 55-0396,
like its analogue mibefradil, cannot be considered as a
specific T-type blocker in the concentration range from
1 to 10 lM. It is therefore crucial for any study making
use of mibefradil and its derivatives as well as any
other putative T-type channel blocker, to perform the
necessary positive and negative control experiments to
verify the specificity of the drugs.
Conclusions
Our data using mice deficient in the CaV3.1 T-type
channel represent new evidence for the involvement
of non-L-type channels in arteriolar tone regulation.
We showed that CaV3.1 channels are important for
maintenance of myogenic tone at an arterial pressure
in the range from 40–80 mm Hg, which is found
under resting conditions in vivo. We also showed
that, contrary to earlier findings in the literature,
CaV3.1 channels are not involved in Ca
2+ entry and
vasoconstriction to large depolarization such as dur-
ing stimulation with high KCl. Finally, we caution
against using NNC 55-0396 as a specific T-type chan-
nel blocker in native cells expressing high-voltage-acti-
vated Ca2+ channels. A candidate for the non-L-type
high-voltage-activated Ca2+ entry channel in mesen-
teric artery myocytes is still missing.
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